BWG Publications, Registration, Presentations and Publicity


Hamilton S, Bernstein AB, Blakey G, Fagan V, Farrow T, Jordan D, Seiler W, Shannon A, Gertel A, Budapest Working Group: Developing the Clarity and Openness in Reporting: E3-based (CORE) Reference user manual for creation of clinical study reports in the era of clinical trials transparency. Research Integrity and Peer Review. 2016. and
Hamilton S, Seiler W, Gertel A: The EMWA Budapest Working Group: A 2-year collaboration to make recommendations for aligning the ICH E3 guidance with current practice and developing clinical study protocol guidance. Medical Writing 2014. and


CORE Reference is registered with as a 'reporting guideline’


Gertel A, Hamilton S (10 May 2019). “CORE Reference 3 Years On - A Resource for Continuing Professional Development”. Presentation including news of BWG review of the TransCelerate CSR template presented at the Regulatory Expert Seminar Series at the EMWA Conference in Vienna
CORE Reference - Three Years On [Slide Deck]
Bernstein A, Gertel A (26 June 2017). “The Core Reference Open Session” presented at the AMWA Conference in Rockville, Maryland, USA.
Ebina H, Fagan V, Gertel A (22 June 2017). Presentation (intermediate level session) at Drug Information Association (DIA) Annual Conference in Chicago, USA. "Driving International Awareness and Use of Regulatory Writing Guidelines: Case Studies of the Clarity and Openness in Reporting (CORE) Reference Guidelines". CORE Reference awareness: DIA 2017 [Slide Deck]
Hamilton S, Farrow T (04 May 2017). Presentation including Utility Survey Results. 5th EMWA Symposium, Birmingham, England.
CORE Reference - One Year On [Slide Deck]CORE Reference - One Year On [Symposium Report and Utility Survey Results]
Hamilton S (01 March 2017). “CORE Reference” [Half day presentation to The Danish Medical Writers Network, hosted by Leo Pharma in Copenhagen]
Bernstein A. (2016, July 17). CORE Reference: A Medical Writer’s Guide to Preparing CSRs in an Evolving Context [Webinar]. American Medical Writers Association Online Learning.

In order to view the video, an AMWA login will need to be created. This is a free registration process for those who are not, or do not wish to become, AMWA members.

Hamilton S. Presentation. CORE Reference launch. Update to EMWA Conference, Munich. 12 May 2016
Hamilton S, Farrow T, Fagan V, Gertel A, Blakey G. Presentation. CORE Reference. Project Update to EMWA Conference, The Hague. 06 November 2015.
Gertel A, Bernstein A, Hamilton S. Presentation. CORE Reference. Project Update to EMWA Conference, Dublin. 06 May 2015.


Hamilton S, Jordan D. ‘CORE Reference - a tool for modern clinical study reports in an era of increasing transparency and disclosure’. Medical Writing 2018;27(2):64-67.
Hamilton S, Forjanic Klapproth J. ‘Streamlining clinical study protocols and reports’. Medical Writing: The Backbone of Clinical Development, Special Edition 2017: 28-31.
Hamilton S, Forjanic Klapproth J. ‘A new standard for medical writing’. WorldPharma Clinical Trials Insight 2016 (2):13-14.
PDF Download
Sam Hamilton's BioMed Central Guest Blog ’Safeguarding the privacy of clinical trial patients’ 27 May 2016:
Press release. CORE Reference launch. 03 May 2016
Press release. CORE Reference project plan. 28 January 2015

Coming soon...

Submitted 07 May 2019 to BioMedCentral's Research Integrity and Peer Review: 

Review of the TransCelerate template for clinical study reports (CSRs) by the developers of CORE Reference (Clarity andOpenness in Reporting: E3-based). Hamilton S, Bernstein AB, Blakey G, Fagan F, Farrow T, Jordan D, Seiler W, Gertel A.

Watch this space for further updates about the progress of this publication.

Third-party Publications and Presentations

The BWG, the developers of CORE Reference are pleased to share the following third-party materials about CORE Reference. The BWG does not accept responsibility for the accuracy of third-party materials. If you have a third-party publication to share, please email:

The TransCelerate Biopharma Clinical Study Report template (November 2018 release) is available on the TransCelerate website under the Common Protocol Template resources.

ICH E3 and CORE Reference are confirmed as the two “well-known standards” used in TransCelerate’s CSR template development in this TransCelerate slide deck.

For further information, read the CORE Reference Press Release.

Note: The developers of CORE Reference were not involved in TransCelerate’s CSR template development.

CORE Reference-related updates are now available in Japanese on a dedicated blog. Thank you to Yukie Uchiyama (responsible for Japanese writing of the blog) and Hiroko Ebina (responsible for quality assurance of the blog) for making this initiative possible.

Note: The opinions expressed in Yukie Uchiyama’s blog, and the interpretations of CORE Reference are solely those of the blogger, and are not necessarily those of the CORE Reference authors.

Ebina H, Homma Y, Woolley KL. Poster P-11 (English translation from the Japanese): CORE Reference: New guidelines of preparing clinical study reports for Japanese biopharmaceutical companies seeking international regulatory approvals. Presented at the 6th General Meeting for the Society of Regulatory Science of Medical Products. 9-10 September 2016, Tokyo, Japan.

Radkova E. Slide presentation. Clarity and Openness in Reporting: E3-based (CORE) Reference. OCT IV Annual Conference - Clinical Trials in and Outside Russia. 19 September 2016, Moscow, Russia.